Sicagen India Limited (BOM:533014)
56.12
+0.62 (1.12%)
At close: Aug 21, 2026
Sicagen India Revenue
Sicagen India had revenue of 2.86B INR in the quarter ending June 30, 2026, with 39.81% growth. This brings the company's revenue in the last twelve months to 10.55B, up 22.07% year-over-year. In the fiscal year ending March 31, 2026, Sicagen India had annual revenue of 9.73B with 9.15% growth.
Revenue (ttm)
10.55B
Revenue Growth
+22.07%
P/S Ratio
0.21
Revenue / Employee
36.63M
Employees
288
Market Cap
2.22B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 9.73B | 816.00M | 9.15% |
| Mar 31, 2025 | 8.92B | 964.30M | 12.12% |
| Mar 31, 2024 | 7.95B | -998.50M | -11.15% |
| Mar 31, 2023 | 8.95B | 591.60M | 7.08% |
| Mar 31, 2022 | 8.36B | 2.95B | 54.37% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Competent Automobiles Company | 26.45B |
| Rathi Steel And Power | 7.54B |
| A-1 Limited | 4.53B |
| Alacrity Securities | 4.50B |
| Prime Fresh | 2.82B |
| Alankit | 2.34B |
| Kings Infra Ventures | 1.57B |
| Novelix Pharmaceuticals | 1.47B |